Evidence map›Paper›PMID 25655630›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2015

Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.

Nickeisha A Stephenson, Jason P Holland, Alina Kassenbrock, Daniel L Yokell, Eli Livni, Steven H Liang, Neil Vasdev

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Recent advances in [Nuclear medicine and biology · 2026
    Review
  2. Triflyl [Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  3. State of the art procedures towards reactive [EJNMMI radiopharmacy and chemistry · 2023
    Review
  4. Detrimental impact of aqueous mobile phases on 18F-labelled radiopharmaceutical analysisAnalytical methods : advancing methods and applications · 2023
    Article
  5. Revisiting the Radiosynthesis of [Molecules (Basel, Switzerland) · 2020
    Article
  6. FacileNature protocols · 2019
    Article
  7. Chemistry for Positron Emission Tomography: Recent Advances inAngewandte Chemie (International ed. in English) · 2019
    Review
  8. Brain mGluR5 in Shank3BFrontiers in psychiatry · 2019
    Article
  9. Article
  10. A first-in-man PET study of [European journal of nuclear medicine and molecular imaging · 2018
    Article
  11. In Vitro and in Vivo Evaluation ofJournal of medicinal chemistry · 2018
    Article
  12. Hypervalent aryliodine compounds as precursors for radiofluorination.Journal of labelled compounds & radiopharmaceuticals · 2018
    Review
  13. A Facile Radiolabeling of [Journal of medicinal chemistry · 2017
    Article
  14. Synthesis and preliminary PET imaging ofNature communications · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nickeisha A StephensonDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and Department of Radiology, Harvard Medical School, Boston, Massachusetts.
Jason P HollandDepartment of Radiology, Harvard Medical School, Boston, Massachusetts.
Alina KassenbrockDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and.
Daniel L YokellDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and.
Eli LivniDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and Department of Radiology, Harvard Medical School, Boston, Massachusetts.
Steven H LiangDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and Department of Radiology, Harvard Medical School, Boston, Massachusetts.
Neil VasdevDivision of Nuclear Medicine and Molecular Imaging, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts; and Department of Radiology, Harvard Medical School, Boston, Massachusetts vasdev.neil@mgh.harvard.edu.

Funding

New PET tracers for neuroimaging of FAAH in endocannabinoid signalingK01DA038000 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI LIANG, STEVEN H · 2014 to 2018
$927k
NIDA NIH HHS K01 DA038000
6 · The paper itself

Abstract

unlabelledTranslation of new methodologies for labeling nonactivated aromatic molecules with (18)F remains a challenge. Here, we report a one-step, regioselective, metal-free (18)F-labeling method that uses a hypervalent iodonium(III) ylide precursor, to prepare the radiopharmaceutical (18)F-3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile ((18)F-FPEB).

methodsAutomated radiosynthesis of (18)F-FPEB was achieved by reaction of the ylide precursor (4 mg) with (18)F-Et4NF in dimethylformamide at 80°C for 5 min and formulated for injection within 1 h.

results(18)F-FPEB was synthesized in 20% ± 5% (n = 3) uncorrected radiochemical yields relative to (18)F-fluoride, with specific activities of 666 ± 51.8 GBq (18 ± 1.4 Ci)/μmol at the end of synthesis and was validated for human use.

conclusionRadiofluorination of iodonium (III) ylides proved to be an efficient radiosynthetic strategy for synthesis of (18)F-labeled radiopharmaceuticals.

Indexed as

AutomationElectronsFluorine RadioisotopesHumansHydrolysisIodineNitrilesOnium CompoundsOxygenPositron-Emission TomographyPyridinesRadiochemistryRadiopharmaceuticalsTemperatureTime Factors3-fluoro-5-((pyridin-3-yl)ethynyl)benzonitrileFluorine RadioisotopesIodineNitrilesOnium CompoundsOxygenPyridinesRadiopharmaceuticals18F-FPEBfluorinationiodonium ylidemGlu5PET

Identifiers

PMID25655630
PMCPMC4878451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.